Kidney Stone Market

Global Statistics Representing Kidney Stone Market Scenario

Kidney stones are solid crystals formed from the salts in urine, it block the flow of urine and cause infection, kidney damage or even kidney failure.

High prevalence of kidney stone across the globe owing to change in lifestyle and eating habits is major factor for driving market growth.   For instance, increasing risk of kidney stones is about 1 in 10 for men and 1 in 35 for women. Around 4 and 8% Australian population suffer from kidney stones every year. After having one kidney stone, the chances of getting a second stone is between 5 and 10 % of people each year. Furthermore, various organization and pharmaceutical industry focus on research & development for innovation of advanced medicine and advanced surgical procedure is propelling the market growth. For instance, in 2018, recent innovation in Kidney Stone Surgery, high-powered laser facilitates is used for stone removal. Rising prevalence of kidney stone owing to growing prevalence of urinary tract infection across the globe is anticipated to drive the market growth. For instance, according to the National Kidney Foundation, around 1 in 5 women have at least one urinary tract infection in her lifetime across the globe.

Global kidney stone market was valued at USD 671.4 million in 2018 and is expected to grow at a CAGR of 4.3 % during the forecast period, 2019–2026.

Intended Audience

• Healthcare Providers (Hospitals, Clinics, and Medical Centers)
• Research Laboratories and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Government & Non-government Organizations
• Market Research and Consulting Firms

Segmentation Insight

Global kidney stone market is segmented by type, treatment type,diagnosis and region

On the basis of type, the market is segmented into calcium oxalate stones, uric acid, struvite kidney stones, cystine stones & calcium phosphate stones. Calcium oxalate stones segment is expected to hold major market share of kidney stone market. Calcium oxalate stones are caused by too much oxalate in the urine. For instance, more than 80% of stones are calcium based, and about 80% of those are calcium oxalate stones. Furthermore, rising consumption of the lowest dietary calcium intake have an increased risk of Calcium oxalate stones.  Furthermore, rising cases of dehydration, hypernatremia, hypercalciuria, and hyperuricosuria are major factor for increasing the chances of calcium oxalate stones. Moreover, it is most commonly occurring kidney stones in the people suffering from diabetes and high obese population is also expected to drive the market growth.  For instance, as per National Diabetes Statistics Report, in 2017, around 30.3 million people, about 9.4% of the U.S. population sustained from diabetes.

On the basis of diagnosis, the market is segmented into ultrasound, intravenous pyelography, CT Scan, X-ray and others. The ultrasound segment is expected to dominate market share during the forecast period owing to it gives anatomical detail of the kidney in a short timeframe, with no exposure to radiation. It is safe and painless test that uses sound waves to make images of the kidneys, ureters, and bladder.

North America to Dominate Global Kidney Stone Market

High prevalence of kidney stone in this region is major factor for driving the market growth. The prevalence of kidney stones was 19% among men, and 9% among women every year. Kidney stones affect approx 1 in 11 people in the United States. Furthermore, prevalence of kidney stones in the United States increased from 3.8% in the late 1970s to 8.8% in the late 2000s. More than 300,000 people diagnosis with kidney diseases each year. Various government and organization, organized different awareness program is also supporting the market growth. For instance, division of nephrology department of medicine organized kidney stone treatment program. High presence of geriatric patient suffering from kidney diseases is also supporting the market growth. For instance, according to the Population Reference Bureau’s, estimation, around 52 million in 2018 and is expected to grow 95 million by 2060 population of age 65-and-older age.

Europe to Witness the Fastest Growth for Global Kidney Stone Market

High prevalene of kidney disases is in U.K., is increasing prevalence of kidney stone is expected to drive the market growth. As per estimation of Kidney Care U.k. in 2015, around 3 million people in the UK have Chronic Kidney Disease. Furthermore, various oragnization focou on rising awerness of kidney disases is also supporting the market growth. For instance,  Kidney Care U.K, NHS Kidney Care, Renal Association UK Renal Registry, And Kidney Research UK, Public Health England are association which are actively involved in organized different program for growing awareness of kidney diseases. Moreover, high prevalence of uncontrolled diabetes and high blood pressure are the biggest causes of various kidney diseases. Moreover, acute kidney infection affects 1 in 5 people admitted to hospital as an emergency, which is major reason for formation of kidney stone.

Our Report Covers

• Historical inferences, findings & analysis of the market from 2016 to 2018
• Projections and performance forecast analysis for future from 2019 to 2026
• Production and consumption point of view (POV) analysis
• Market drivers, restraint and opportunity analysis to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
• Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability and future prospects

Key Players

Some of the key players in the Global kidney stone market are Boston Scientific Corporation, Convergent Laser Technologies, DirexGroup, Siemens Healthcare GmbH, C.R. Bard Inc, Cook Medical Inc, Dornier MedTech GmbH, Richard Wolf Medical Instruments Corporation, Olympus Corporation, and Stryker Corporation.

Kidney Stone Market Segmentation

By Type

• Calcium Oxalate Stones
• Uric Acid
• Struvite Kidney Stones
• Cystine Stones
• Calcium Phosphate Stones

By Treatment Type

• Medications
• Extracorporeal Shock Wave Lithotripsy
• Ureteroscopy
• Percutaneous Nephrolithotomy

By Diagnosis

• Ultrasound
• Intravenous Pyelography
• CT Scan
• X-Ray
• Others

Regions covered

America

o    North America

• U.S.
• Canada
• Mexico

o    South America

Europe

o    Western Europe

• Germany
• France
• U.K
• Italy
• Spain
• Rest of Western Europe

o    Eastern Europe

Asia Pacific

o    China

o    India

o    Japan

o    South Korea

o    Australia

o    Rest of Asia Pacific

The Middle East & Africa

o    The Middle East

• Saudi Arabia
• UAE
• Qatar
• Rest of the Middle East

o    Africa